ClinicalTrials.Veeva

Menu

Incidence and Effects of Sleep Apnea on Intracerebral Aneurysms (IESA)

U

University Hospital Bonn (UKB)

Status

Unknown

Conditions

Blood Pressure Medication
Intracranial Aneurysm Size
Complications (Subarachnoid Hemorrhage)
Comorbidities
Sleep Apnea (Defined as Apnea Hypopnea Index > 5/h)

Treatments

Device: Cardiorepiratory Polygraphy

Study type

Observational

Funder types

Other

Identifiers

NCT02880059
IESA-Study

Details and patient eligibility

About

Patients with intracerebral aneurysm will be screened for sleep apnea using out of center polysomnography/polygraphy. Baseline blood pressure and medication will be assessed. Patients will be followed for up to 5 years to examine the increase in aneurysm size, rupture rate and changes in medication.

Full description

Patient presenting to the outpatient center for neurological of neurosurgical management of intracerebral aneurysm will be recruited. Sleep apnea will be assessed by questionnaire and out of center polygraph/polysomnography. Medication, comorbidities and blood pressure will be recorded. Change in aneurysm size and blood pressure medication will be evaluated annually for up to 5 years. Frequency of subarachnoid hemorrhage and increase in aneurysm size will be assessed.

Enrollment

200 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Intracerebral aneurysm
  • Age >= 18yrs.
  • Ability to give informed consent

Exclusion criteria

  • Stroke within 3 month of study inclusion.

Trial contacts and locations

1

Loading...

Central trial contact

Erdem Guersir, MD, PhD; Sebastian Zaremba, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems